Antibodies to human CK&bgr;-10/MCP-4
    4.
    发明授权
    Antibodies to human CK&bgr;-10/MCP-4 失效
    人类CKbeta-10 / MCP-4的抗体

    公开(公告)号:US06673344B1

    公开(公告)日:2004-01-06

    申请号:US09717209

    申请日:2000-11-22

    CPC classification number: C07K14/52 C07K14/523 Y10S930/14

    Abstract: Human chemokine polypeptides and DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemokine polypeptides and their use as a therapeutic to treat rheumatoid arthritis, autoimmune and chronic inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever and bone marrow failure are also disclosed.

    Abstract translation: 公开了人趋化因子多肽和编码这种趋化因子多肽的DNA(RNA)和通过重组技术产生此类多肽的方法。 还公开了利用这种趋化因子多肽治疗白血病,肿瘤,慢性感染,自身免疫疾病,纤维化病症,伤口愈合和牛皮癣的方法。 还公开了抗这种趋化因子多肽的拮抗剂及其作为治疗类风湿性关节炎,自身免疫性和慢性炎性和感染性疾病,过敏反应,前列腺素依赖性发烧和骨髓衰竭的治疗剂的用途。

Patent Agency Ranking